We are live on
!
Find out more
TCP
Tourbillon Capital Partners Portfolio holdings
AUM
$6.26M
1-Year Est. Return
42.29%
This Fund
S&P 500
This Quarter
Est. Return
-47.35%
1 Year Est. Return
-42.29%
3 Year Est. Return
-18.38%
5 Year Est. Return
+32.21%
10 Year Est. Return
–
AUM
$6.26M
AUM Growth
-$923M
(-99%)
Cap. Flow
-$610M
Cap. Flow
% of AUM
-9,738.48%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
34
New
–
Increased
1
Reduced
–
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
STKL
SunOpta
STKL
|
+$5.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WP
Worldpay, Inc.
WP
|
+$49M |
| 2 |
LPL Financial
LPLA
|
+$47.8M |
| 3 |
GDS Holdings
GDS
|
+$42.1M |
| 4 |
EA
Electronic Arts
EA
|
+$40.4M |
| 5 |
Visa
V
|
+$39.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 100% |
| 2 | Communication Services | 0% |
| 3 | Consumer Discretionary | 0% |
| 4 | Financials | 0% |
| 5 | Healthcare | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STKL
1
DELISTED
SunOpta
STKL
| $6.26M | 100% |
1,617,690
+1,051,356
| +186% | +$5.99M |
|
2
Alibaba
BABA
$279B
| – | – |
-150,000
| Closed | -$24.7M |
|
3
BGC Group
BGC
$5.72B
| – | – |
-4,100,757
| Closed | -$31.2M |
|
4
BioMarin Pharmaceuticals
BMRN
$12.8B
| – | – |
-147,193
| Closed | -$14.3M |
|
5
Popular Inc
BPOP
$10.9B
| – | – |
-612,795
| Closed | -$31.4M |
|
6
PUT
Clorox
CLX
$11.3B
| – | – |
-100,000
| Closed | -$15M |
|
|
EA
7
DELISTED
Electronic Arts
EA
| – | – |
-335,000
| Closed | -$40.4M |
|
|
FOLD
8
DELISTED
Amicus Therapeutics
FOLD
| – | – |
-1,414,130
| Closed | -$17.1M |
|
|
9
CALL
GDS Holdings
GDS
$6.27B
| – | – |
-250,000
| Closed | -$8.78M |
|
|
10
GDS Holdings
GDS
$6.27B
| – | – |
-1,197,921
| Closed | -$42.1M |
|
11
Gilead Sciences
GILD
$185B
| – | – |
-496,121
| Closed | -$38.3M |
|
12
Humana
HUM
$48.6B
| – | – |
-90,784
| Closed | -$30.7M |
|
13
iShares Russell 2000 ETF
IWM
$80.7B
| – | – |
-100,000
| Closed | -$16.9M |
|
14
Krystal Biotech
KRYS
$11B
| – | – |
-141,198
| Closed | -$2.48M |
|
|
15
LPL Financial
LPLA
$28.2B
| – | – |
-740,890
| Closed | -$47.8M |
|
16
PUT
McCormick & Company Non-Voting
MKC
$13.9B
| – | – |
-100,000
| Closed | -$6.59M |
|
17
CALL
Morgan Stanley
MS
$339B
| – | – |
-500,000
| Closed | -$23.3M |
|
18
Netflix
NFLX
$343B
| – | – |
-700,000
| Closed | -$26.2M |
|
19
PUT
iShares S&P 100 ETF
OEF
$20.6B
| – | – |
-600,000
| Closed | -$101M |
|
20
Puma Biotechnology
PBYI
$498M
| – | – |
-285,091
| Closed | -$13.1M |
|
21
Spectrum Brands
SPB
$2.02B
| – | – |
-316,400
| Closed | -$23.6M |
|
22
State Street SPDR S&P 500 ETF Trust
SPY
$817B
| – | – |
-50,000
| Closed | -$14.5M |
|
|
23
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$817B
| – | – |
-500,000
| Closed | -$145M |
|
24
Stryker
SYK
$117B
| – | – |
-100,000
| Closed | -$17.8M |
|
|
25
Visa
V
$703B
| – | – |
-264,930
| Closed | -$39.8M |
|
Similar funds
BC
LBG
ACM
MGFS
LA
CT
NMM
HMC
Tourbillon Capital Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Tourbillon Capital Partners held 34 positions worth $6.26M, down 99% from $929M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Tourbillon Capital Partners withdrew a net $610M in Q4 2018, closing 33 positions. Its most notable exit was Worldpay, Inc., an estimated $49M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 100% of assets, up from 3% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Tourbillon Capital Partners added an estimated $5.99M to SunOpta.
- Tourbillon Capital Partners added most to SunOpta in Q4 2018, an estimated $5.99M increase.
- Tourbillon Capital Partners fully exited Worldpay, Inc. in Q4 2018, selling an estimated $49M.
- Tourbillon Capital Partners's ten largest holdings make up 100% of its $6.26M portfolio in Q4 2018.
- Tourbillon Capital Partners opened 0 new positions and closed 33 in Q4 2018.
- Tourbillon Capital Partners's portfolio value fell 99% quarter-over-quarter to $6.26M.
Based on Tourbillon Capital Partners's 13F filing for Q4 2018, filed 14 Feb 2019.